Headlines in Urology Treatment

Diet And Medications May Assist Prevention Of Prostate Cancer

Recent investigations of medications, diet and the molecular understanding of prostate cancer are defining potential prevention strategies for the disease, and herald a new stage in the management of this cancer, according to a new review.

Writing in the November 1, 2007 issue of Cancer, Dr. Neil Fleshner and Dr. Alexandre Zlotta from the University of Toronto say that available medications, such as 5-alpha reductase inhibitors and selective estrogen receptor modifiers, show promise in reducing malignancies. In addition, there is strong evidence that dietary fat significantly impacts disease development and promising data that other compounds, such as soy, selenium and green tea, offer additional possibilities for disease prevention.

Pomegranate Juice May Fight Cancer

Natural chemicals in pomegranate juice may slow the growth of prostate cancer, according to scientists at the University of California at Los Angeles.

The key pomegranate chemicals, called ellagitannins, are also found in foods including strawberries, raspberries, and muscadine grapes, note Navindra Seeram, Ph.D., and colleagues.

Cut the risk of aggressive prostate cancer by eating broccoli and cauliflower

According to a new NCI study led by Dr. Richard B. Hayes, men may be able to cut their risk of aggressive prostate cancer in half by adding broccoli and cauliflower to their diets.

Hayes and his team found that men who ate more than a serving of either vegetable each week had half the risk of advanced prostate cancer compared with men who ate these vegetables less than once a month.

Canadian-led study aims to answer thorny prostate cancer question

Canadian researchers are launching a large, multi-year international study to try to find a way to help the hundreds of thousands of men diagnosed with prostate cancer every year decide whether to opt for potentially life-altering treatments or choose a watch-and-wait approach.

The Canadian Cancer Society and the National Cancer Institute of Canada announced the study Thursday, saying it is hoped the START trial - the acronym stands for Surveillance Therapy Against Radical Treatment - will resolve one of the thorniest dilemmas in prostate cancer care.

Combination treatment for high-risk prostate cancer

According to research carried out by Dr. Michael Dattoli, of the Dattoli Cancer Center, Sarasota, Florida, high rates of tumor control are possible over the long term in high-risk prostate cancer patients with combination treatment consisting of external beam radiation followed by brachytherapy.

The risk of bladder cancer might be reduced by NSAIDs

Non-steroidal anti-inflammatory drugs (NSAIDs), especially aspirin, may decrease the risk of bladder cancer according to a new study led by Dr. Margaret Karagas of Dartmouth Medical School.

The findings point to a decrease in risk for bladder cancer, especially advanced, high-grade tumors that contain alternations in the tumor suppressor protein TP53, with NSAID use. There was no correlation between the use of acetaminophen and risk of bladder cancer.

Prostate drug cleared of causing aggressive tumors

A hair-loss drug that can also prevent prostate cancer may offer a third benefit by helping doctors detect the most aggressive prostate tumors earlier, U.S. and Israeli researchers reported on Tuesday. They said they could dispel fears that finasteride might somehow cause the high-grade tumors. Two studies published in the Journal of the National Cancer Institute show that the drug appears to be keeping the prostate gland small, making it easier to find dangerous tumors inside or on the surface.

Stem cells treat urinary incontinence

About 13-million Americans are living with urinary incontinence -- a condition that causes the bladder to leak urine. It's nearly twice as common in women, and many don't seek help. Surgical slings, pills and exercises are some common treatments, but now a new breakthrough could offer some patients a life free of embarrassment.

Fat, chance and cancer

The nation's obesity epidemic is exposing the alarming link between body fat and cancer.

A dramatic increase in a deadly form of oesophagus cancer linked to obesity suggests excess body fat is driving the disease.

David Whiteman, a senior research fellow at the Queensland Institute of Medical Research, said adenocarcinoma had increased five fold in the past 25 years in Australia - an "unprecedented" rise.

Micronutrient Benefit For Prostate Cancer Ruled Out

None of 10 micronutrients -- such as carotenoids, retinol, and tocopherols -- appears to help prevent prostate cancer, found investigators here.

The European Prospective Investigation into Cancer and Nutrition study found that none of the 10 micronutrients analyzed prevented prostate cancer, according to Timothy Key, D.Phil., of Oxford University and colleagues.